The HIV-infected population in the Netherlands is aging, both as a result of effective combination antiretroviral therapy, and the relative increase in the number of newly diagnosed HIV infections among older people. As the mean age of HIV-positive patients increases, so does the prevalence of non-HIV-associated comorbidities, possibly at higher rates than observed in the general population. As people with HIV continue to age, they will be more likely to experience multimorbidity, polypharmacy, and to receive care from diverse healthcare professionals. It is therefore important that all healthcare professionals have up-to-date knowledge of HIV and the emerging health-care challenges concerning aging people with HIV.
Aging Anti-Retroviral Agents